Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
8-Feb-10 PriceTarget Research, Inc. N/A Lemaitre Vascular has a current Overall Rating of B (Positive). 7 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: LEMAITRE VASCULA -- LMAT 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: CLRT , LMAT , LMNX , MLAB , MEND , NXTM , PMTI -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of LEMAITRE VASCULAR INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for LMAT: the economy's impact on LMAT's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Lemaitre Vascular, Inc. 40 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: LEMAITRE VASCULAR INC 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: LEMAITRE VASCULAR INC 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: LEMAITRE VASCULAR INC 5 $25 View Abstract
5-Jan-10 Global Markets Direct Global Markets Direct LeMaitre Vascular, Inc. Financial and Strategic Analysis Review 39 $300 View Abstract
Next 9

Independent Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price More Info
8-Feb-10 PriceTarget Research, Inc. N/A Lemaitre Vascular has a current Overall Rating of B (Positive). 7 $25 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: LEMAITRE VASCULA -- LMAT 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: CLRT , LMAT , LMNX , MLAB , MEND , NXTM , PMTI -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of LEMAITRE VASCULAR INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for LMAT: the economy's impact on LMAT's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
31-Jan-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Lemaitre Vascular, Inc. 40 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: LEMAITRE VASCULAR INC 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: LEMAITRE VASCULAR INC 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: LEMAITRE VASCULAR INC 5 $25 View Abstract
5-Jan-10 Global Markets Direct Global Markets Direct LeMaitre Vascular, Inc. Financial and Strategic Analysis Review 39 $300 View Abstract
Next 9

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.